Bruush Oral Care Inc. BRSHF
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $8.7M
- P/E
- 0.0×
Follow BRSHF
Growth Flags
show if company had growth for consecutive years
| Apr '23 | Mar '23 | Jan '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
| 131.00% | 199.66% | 0.00% | — |
+5 more TTM periods Free account |
|
| (413.95%) | (630.83%) | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
83.26% | 126.77% | 0.00% | 0.00% | |
Average Days of Receivables |
31.95 | 32.39 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(19.04) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(9.50) | (1.39) | (0.12) | (0.12) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Piotroski F-Score |
0.00 | 1.00 | — | — | |
| Other line items | |||||
Cash ROIC |
358.87% | 52.39% | 9.58% | 9.55% | |
Accounts Receivable Turnover |
10.63 | 10.49 | 0.00 | — | |
Accounts Payable Turnover |
0.68 | 0.69 | 0.00 | — | |
Inventory Turnover |
6.48 | 6.58 | 0.00 | — | |
Average Days of Payables |
676.76 | 666.97 | 0.00 | 0.00 | |
Days of Inventory on Hand |
41.92 | 41.31 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.17% | 0.09% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
533.91% | 531.41% | — | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | |
Interest Coverage |
0.00 | 0.00 | — | — | |
Operating CF/Net income |
2.20 | 0.21 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.86 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.67) | (0.17) | (0.36) | (0.36) | |
Revenue per Share |
3.50 | 0.00 | — | — | |
Operating CF per Share |
(19.03) | 0.00 | 0.00 | 0.00 | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(247.19%) | (381.86%) | — | — |
Columns are period end dates